Home › All Companies › CCEL › Quarterly Report

CRYO CELL INTERNATIONAL INC (CCEL) — Quarterly Report

AI-Powered SEC Filing Analysis

← All CCEL filings
Latest Quarterly Report Filed: 2026-04-14

Key Insights

  • The company has entered into a new licensing agreement with Duke University, which could provide access to new stem cell technologies and potentially expand the company's product offerings.
  • The company has obtained a revolving credit facility and term loan, which could provide additional financing flexibility to support its operations and growth initiatives.
  • The company has granted stock options with market-based vesting conditions to its co-CEOs and other key executives, potentially aligning their interests with shareholders.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for CRYO CELL INTERNATIONAL INC

Current Report Annual Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.